Clinical and hematologic response of chronic lymphocytic and prolymphocytic leukemia persisting after allogeneic bone marrow transplantation with the onset of acute graft-versus-host disease: Possible role of graft-versus-leukemia

被引:0
作者
Mehta, J
Powles, R
Singhal, S
Iveson, T
Treleaven, J
Catovsky, D
机构
关键词
chronic lymphocytic leukemia; corticosteroids; cyclosporine; graft-versus-host disease; graft-versus-leukemia; prolymphocytic leukemia;
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
One patient with refractory B cell chronic lymphocytic leukemia (CLL) and another with refractory B cell prolymphocytic leukemia (PLL) underwent bone marrow transplantation (BMT) from HLA-identical siblings, Circulating malignant cells persisted at high levels in the patient with PLL and there was clinical evidence of disease progression soon after transplant in the patient with CLL. Starting 4-5 weeks post-BMT, cyclosporine was tapered rapidly to stimulate immunologic graft-versus-leukemia (GVL) reactions, There was a fall in the number of malignant cells and reversal of organomegaly with the onset of acute graft-versus-host disease (GVHD), Both patients received conventional doses of corticosteroids for GVHD which also may have contributed to disease response to some extent, Total clearance of the leukemic cells from the peripheral blood was seen in both patients, and clearance of the marrow was seen in the patient with CLL, However, both patients died of complications of severe GVHD, We conclude that GVHD may be associated with a GVL effect after allogeneic BMT for refractory chronic B cell lymphoproliferative diseases, Whether GVL reactions occur in the absence of clinically obvious GVHD after allogeneic BMT for CLL remains to be seen.
引用
收藏
页码:371 / 375
页数:5
相关论文
共 26 条
[1]  
BANDINI G, 1991, BONE MARROW TRANSPL, V7, P251
[2]  
COLLINS RH, 1992, BONE MARROW TRANSPL, V10, P391
[3]  
HIGANO CS, 1990, TRANSPLANTATION, V50, P175
[4]  
JARQUE I, 1993, BLOOD, V82, P1036
[5]   AUTOLOGOUS AND ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC-LEUKEMIA - PRELIMINARY-RESULTS [J].
KHOURI, IF ;
KEATING, MJ ;
VRIESENDORP, HM ;
READING, CL ;
PRZEPIORKA, D ;
HUH, YO ;
ANDERSSON, BS ;
VANBESIEN, KW ;
MEHRA, RC ;
GIRALT, SA ;
IPPOLITI, C ;
MARSHALL, M ;
THOMAS, MW ;
OBRIEN, S ;
ROBERTSON, LE ;
DEISSEROTH, AB ;
CHAMPLIN, RE .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (04) :748-758
[6]   DONOR LEUKOCYTE TRANSFUSIONS FOR TREATMENT OF RECURRENT CHRONIC MYELOGENOUS LEUKEMIA IN MARROW TRANSPLANT PATIENTS [J].
KOLB, HJ ;
MITTERMULLER, J ;
CLEMM, C ;
HOLLER, E ;
LEDDEROSE, G ;
BREHM, G ;
HEIM, M ;
WILMANNS, W .
BLOOD, 1990, 76 (12) :2462-2465
[7]  
MEHTA J, 1995, BONE MARROW TRANSPL, V16, P133
[8]  
Mehta J., 1995, Blood, V86, p958A
[9]  
Mehta J., 1994, British Journal of Haematology, V86, P81
[10]   GRAFT-VERSUS-LEUKEMIA REACTIONS IN CLINICAL BONE-MARROW TRANSPLANTATION [J].
MEHTA, J .
LEUKEMIA & LYMPHOMA, 1993, 10 (06) :427-432